Ezetimibe and Wound secretion - a phase IV clinical study of FDA data

Summary:

Wound secretion is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Allopurinol, and have Crohn's disease.

The phase IV clinical study analyzes which people have Wound secretion when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Wound secretion?

Wound secretion is found to be associated with 571 drugs and 761 conditions by eHealthMe. Check the latest studies of Wound secretion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 27 people (0.09%) have Wound secretion.

Among these 27 people:

How long have people been on Ezetimibe when they have Wound secretion? *

What is the gender of people who have Wound secretion when taking Ezetimibe? *

female: 45 %
male: 55 %

What is the age of people who have Wound secretion when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

What are other side effects people have besides Wound secretion? *

Limb Injury: 19 people, 70.37%
Headache (pain in head): 14 people, 51.85%
Joint Pain: 13 people, 48.15%
Oedema Peripheral (superficial swelling): 13 people, 48.15%
Wound Complication: 12 people, 44.44%
Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 12 people, 44.44%
Drug Ineffective: 10 people, 37.04%
Diarrhea: 10 people, 37.04%
Scab (a hard coating on the skin formed during the wound healing): 10 people, 37.04%
Rashes (redness): 8 people, 29.63%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 12 people, 44.44%
Type 2 Diabetes: 3 people, 11.11%
Seasonal Allergy (allergic condition due to certain season): 3 people, 11.11%
Pain: 3 people, 11.11%
High Blood Pressure: 3 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.11%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 11.11%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.70%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 3.70%
Hepatitis C: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Wound secretion?

- Check whether Wound secretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,849 reports)

Wound secretion treatments and more:

Wound secretion (5,127 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Wound secretion:

Wound secretion (571 drugs)

Browse all the conditions that are associated with Wound secretion:

Wound secretion (761 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.